Variant report
Variant | nsv980960 |
---|---|
Chromosome Location | chr5:114640484-114645980 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:114645171..114646099-chr5:114908180..114909218,4 | K562 | blood: | |
2 | chr5:114640336..114642375-chr5:114647745..114650691,2 | K562 | blood: | |
3 | chr5:114645305..114646120-chr5:115403049..115404011,2 | K562 | blood: | |
4 | chr5:114644466..114646908-chr5:114878278..114881087,2 | MCF-7 | breast: | |
5 | chr5:114640840..114642541-chr5:114647745..114650206,3 | K562 | blood: | |
6 | chr5:114645535..114646139-chr5:114921972..114922517,2 | MCF-7 | breast: | |
7 | chr5:114629727..114632904-chr5:114639904..114644265,4 | MCF-7 | breast: | |
8 | chr5:114645258..114646128-chr5:114921954..114922997,3 | K562 | blood: | |
9 | chr5:114630713..114633378-chr5:114639013..114640767,2 | MCF-7 | breast: | |
10 | chr5:114645138..114646056-chr5:114908059..114908645,2 | MCF-7 | breast: | |
11 | chr5:114645624..114646196-chr5:114709538..114710375,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000145780 | chromatin interactions |
ENSG00000164221 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562490044 | chr5:114640501-114640502 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs13175151 | chr5:114640536-114640537 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs551402069 | chr5:114640563-114640564 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs180843748 | chr5:114640626-114640627 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs981825 | chr5:114640636-114640637 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs185895612 | chr5:114640650-114640651 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs567378399 | chr5:114640675-114640676 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2112362 | chr5:114640689-114640690 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs556227334 | chr5:114640690-114640691 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs202206432 | chr5:114640728-114640729 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs188317035 | chr5:114640842-114640843 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs540081871 | chr5:114640885-114640886 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs75097662 | chr5:114640886-114640887 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs558536344 | chr5:114640887-114640888 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs558370323 | chr5:114640896-114640897 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs572173239 | chr5:114640936-114640937 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs139702019 | chr5:114640957-114640958 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs11948462 | chr5:114640979-114640980 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs76036513 | chr5:114640998-114640999 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs530262662 | chr5:114641108-114641109 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs142336755 | chr5:114641114-114641115 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs563871201 | chr5:114641159-114641160 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs555082257 | chr5:114641262-114641263 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs181167639 | chr5:114641271-114641272 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs538930933 | chr5:114641308-114641309 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559223830 | chr5:114641309-114641310 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs370258325 | chr5:114641350-114641351 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs571286963 | chr5:114641456-114641457 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs527362975 | chr5:114641550-114641551 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs547209662 | chr5:114641635-114641636 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs567446567 | chr5:114641642-114641643 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs151274643 | chr5:114641694-114641695 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs556325246 | chr5:114641753-114641754 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs140423201 | chr5:114641755-114641756 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs538561713 | chr5:114641824-114641825 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs185814188 | chr5:114641828-114641829 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs373570148 | chr5:114641878-114641879 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs150406190 | chr5:114641879-114641880 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs541496988 | chr5:114641907-114641908 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs572431588 | chr5:114641934-114641935 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs190575718 | chr5:114641950-114641951 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs183178176 | chr5:114641962-114641963 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs17137619 | chr5:114641964-114641965 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs376982669 | chr5:114641992-114641993 | Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs7734924 | chr5:114642041-114642042 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs187181755 | chr5:114642050-114642051 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs146627738 | chr5:114642060-114642061 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs543117584 | chr5:114642072-114642073 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs192108910 | chr5:114642083-114642084 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs141404419 | chr5:114642087-114642088 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114632200-114641800 | Weak transcription | Stomach Mucosa | stomach |
2 | chr5:114641600-114642000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr5:114641600-114642200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:114641600-114642200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr5:114641600-114642200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr5:114641600-114642400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
7 | chr5:114641800-114642000 | Flanking Bivalent TSS/Enh | Pancreas | Pancrea |
8 | chr5:114641800-114642200 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr5:114641800-114642200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr5:114641800-114642200 | Enhancers | Fetal Intestine Small | intestine |
11 | chr5:114641800-114642200 | Enhancers | Stomach Mucosa | stomach |
12 | chr5:114641800-114642400 | Enhancers | Brain Germinal Matrix | brain |
13 | chr5:114641800-114642600 | Enhancers | Duodenum Mucosa | Duodenum |
14 | chr5:114642000-114642400 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
15 | chr5:114642200-114651200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr5:114642200-114651400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
17 | chr5:114642400-114647400 | Weak transcription | Brain Germinal Matrix | brain |
18 | chr5:114645200-114645600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr5:114645400-114645600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
20 | chr5:114645400-114645600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr5:114645600-114646200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr5:114645600-114648000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |